BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for patients with bone metastases from breast cancer, and also appeared to be ...
"It wasn’t until I developed a random blind spot in my eye that my mom took me to the ER. They ordered a head CT that caught ...
Most prostate cancers are first found as a result of screening through a Prostate-specific antigen (PSA) blood test. (Patrick T. Fallon/Bloomberg via Getty Images) Prostate cancer is the most common ...
Researchers at Cleveland Clinic Children's have helped identify a previously unknown gene that increases the risk of developing osteosarcoma, the most common type of malignant bone tumor in children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback